LobbyingNavitus Health Solutions lobbying by quarter
Navitus Health Solutions's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q1 2023; the issues it reports most are Health Issues and Insurance.
Navitus Health Solutions
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2023 | $20K | 1 |
| Q2 2023 | $7,500 | 1 |
| Q3 2023 | $7,000 | 1 |
| Q4 2023 | $6,000 | 1 |
| Q1 2024 | $30K | 1 |
| Q2 2024 | $30K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $30K | 1 |
| Q1 2025 | $15K | 1 |
| Q2 2025 | $30K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$98.5K · 14 reports
- Insurance$98.5K · 14 reports
- Pharmacy$98.5K · 14 reports
- Labor, antitrust and workplace$30K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
- Health & Human Services, Dept of (HHS)10 reports
- Labor, Dept of (DOL)10 reports
- Internal Revenue Service (IRS)8 reports
- Treasury, Dept of8 reports
- Federal Trade Commission (FTC)7 reports
- Food & Drug Administration (FDA)6 reports
- White House Office5 reports
- Natl Economic Council (NEC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseNavitus Health Solutions | $325.5K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/07for Q2 | In-house | $30K |
| 04/15for Q1 | In-house | $30K |
| 01/12for Q4 2025 | In-house | $30K |
| 25/10/20for Q3 2025 | In-house | $30K |
| 25/07/20for Q2 2025 | In-house | $30K |
| 25/06/22for Q1 2025 | In-house | $15K |
| 25/04/21for Q1 2025 | In-house | $30K |
| 25/01/19for Q4 2024 | In-house | $30K |
| 24/10/21for Q3 2024 | In-house | $30K |
| 24/07/22for Q2 2024 | In-house | $30K |
| 24/04/20for Q1 2024 | In-house | $30K |
| 24/01/02for Q4 2023 | In-house | $6,000 |
| 23/10/19for Q3 2023 | In-house | $7,000 |
| 23/07/31for Q2 2023 | In-house | $7,500 |
| 23/06/13for Q1 2023 | In-house | $20K |
| 23/04/20for Q1 2023 | In-house | Under $5,000 |